Home › Funds › Fortis Group Advisors, LLC › PPH
Fortis Group Advisors, LLC position in PPH
VANECK PHARMACEUTICAL ETF
Fortis Group Advisors, LLC reported holding 31,593 shares of PPH (VANECK PHARMACEUTICAL ETF) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.60% of its reported portfolio and ranking #49 among its reported holdings. Fortis Group Advisors, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Fortis Group Advisors, LLC's PPH position evolved
Fortis Group Advisors, LLC first disclosed a stake in PPH in Q3 2026 at 31,593 shares (US$3.8M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 31.59K | $3.77M | New |
About PPH and 13F data
PPH (VANECK PHARMACEUTICAL ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in PPH — the largest reported positions include J.Safra Asset Management Corp (US$35.9M), Avalon Trust Co (US$27.8M), ADAMSBROWN WEALTH CONSULTANTS LLC (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PPH
- J.Safra Asset Management Corp 328.31K sh · $35.94M · Q3 2026
- Avalon Trust Co 254.16K sh · $27.82M · Q3 2026
- ADAMSBROWN WEALTH CONSULTANTS LLC 101.70K sh · $11.13M · Q3 2026
- Rye Brook Capital LLC 70.25K sh · $7.69M · Q3 2026
- WT Wealth Management 47.80K sh · $5.23M · Q3 2026
- Fluent Financial, LLC 26.90K sh · $2.94M · Q3 2026
More on Fortis Group Advisors, LLC
FAQ
How long has Fortis Group Advisors, LLC held PPH?
Fortis Group Advisors, LLC has disclosed PPH holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Fortis Group Advisors, LLC's current position in PPH?
As of Q3 2026, Fortis Group Advisors, LLC holds 31.59K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $3.77M, representing 0.60% of its reported portfolio and ranking #49.
Has Fortis Group Advisors, LLC been buying or selling PPH?
In the latest 13F filing (Q3 2026), Fortis Group Advisors, LLC newly opened its position in PPH.
Which other funds hold PPH?
Other major institutional holders of PPH include J.Safra Asset Management Corp, Avalon Trust Co, ADAMSBROWN WEALTH CONSULTANTS LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.